Buscar en
Allergologia et Immunopathologia
Toda la web
Inicio Allergologia et Immunopathologia Beyond anti-microbial properties: The role of cathelicidin in allergic rhinitis
Journal Information
Vol. 44. Issue 4.
Pages 297-302 (July - August 2016)
Share
Share
Download PDF
More article options
ePub
Vol. 44. Issue 4.
Pages 297-302 (July - August 2016)
Original article
DOI: 10.1016/j.aller.2015.07.006
Beyond anti-microbial properties: The role of cathelicidin in allergic rhinitis
Visits
...
F. Dileka,
Corresponding author
drfatihdilek@yahoo.com

Corresponding author.
, B. Gultepeb, E. Ozkayaa, M. Yazicia, A.H. Gedikc, E. Cakirc
a Department of Pediatric Allergy and Immunology, Bezmialem Vakif University Medical Faculty, Adnan Menderes Bulvari, Vatan Caddesi, 34093 Fatih, Istanbul, Turkey
b Department of Clinical Microbiology, Bezmialem Vakif University Medical Faculty, Adnan Menderes Bulvari, Vatan Caddesi, 34093 Fatih, Istanbul, Turkey
c Department of Pediatric Pulmonology, Bezmialem Vakif University Medical Faculty, Adnan Menderes Bulvari, Vatan Caddesi, 34093 Fatih, Istanbul, Turkey
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Tables (1)
Table 1. Demographic and clinical features of the study and control groups.
Abstract
Background

Cathelicidin, an anti-microbial peptide, is a component of the innate immune system. Cathelicidin has anti-microbial, anti-inflammatory and immunoregulatory functions. Knowledge about the role of the innate immune system in the pathogenesis of allergic diseases has expanded in recent years. We measured levels of the LL-37 peptide in the nasal fluids of children with allergic rhinitis (AR) and investigated the possible role of this peptide in the pathogenesis of AR.

Methods

The study population included 46 children who were newly diagnosed with AR and not taking any medication. Thirty-three healthy control subjects were also enrolled. Nasal secretions were collected from the study and control groups using a polyurethane sponge nasal secretion collector, and nasal fluid LL-37 levels were determined using the ELISA method.

Results

The levels of LL-37 in the nasal fluid of the AR patients were lower than those of the control group (median of 2.3ng/ml [minimum–maximum, 2.1–3.2] vs. 2.6ng/ml [2.1–5.4], respectively; p<0.001), and they were significantly reduced in patients with moderate/severe AR compared with those of patients with mild AR (2.2ng/ml [2.1–2.4] vs. 2.5ng/ml [2.1–3.1], respectively; p<0.001).

Conclusion

Our results show that children with AR have reduced nasal fluid LL-37 levels compared with healthy controls. Additionally, children with moderate/severe AR have decreased nasal fluid LL-37 levels compared with children with mild AR. These findings highlight the role of cathelicidin in the pathogenesis of AR.

Keywords:
Allergic rhinitis
Nasal fluid
Disease severity
Cathelicidin
LL-37

Article

These are the options to access the full texts of the publication Allergologia et Immunopathologia
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Allergologia et Immunopathologia

Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Precio 22,50 €

Comprar ahora
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.